title: Discrimination between drug-resistant and non-resistant human melanoma cell lines by FTIR spectroscopy.
abstract: We investigated the ability of FTIR-microscopy to define spectral changes between drug-sensitive and drug-resistant human melanoma cells. As a model system, a resistant melanoma cell line (GAC) was selected with cisplatin from parental (GA) cells. Using Fourier transform infrared spectroscopy (FTIR) we investigated the ability to differentiate between the resistant variant derived from the sensitive parental cell line, in the absence of cisplatin. We determined and validated spectral parameters (biomarkers) that differentiated between the two cell lines. By applying the principal component analysis (PCA) model, we reduced the original data size to six principal components. We detected a significant and consistent increase in the cell's DNA/RNA ratio as well as an increase in the lipid/protein ratio in the resistant cells. These results strongly support the potential of developing FTIR microspectroscopy as a simple, reagent-free method for the identification of drug-resistant cells. Rapid detection of tumors resistant to a particular drug, should contribute to the ability of the physician to choose an effective treatment protocol.
authors.affiliation: Department of Physics and the Cancer Research Center, Ben-Gurion University (BGU), Beer-Sheva, 84105, Israel.
authors.forename: A
authors.initials: A
authors.lastname: Zwielly
authors.forename: J
authors.initials: J
authors.lastname: Gopas
authors.forename: G
authors.initials: G
authors.lastname: Brkic
authors.forename: S
authors.initials: S
authors.lastname: Mordechai
mesh_terms: D000465:Algorithms; D000970:Antineoplastic Agents / Q000627:therapeutic use; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008545:Melanoma / Q000175:diagnosis* / Q000188:drug therapy; D025341:Principal Component Analysis; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D017550:Spectroscopy, Fourier Transform Infrared
chemical_list: D000970:Antineoplastic Agents